Evaluation of Abuse Potential of Synthetic Cathinones Using IN Vivo Pharmacological Studies

The Drug Enforcement Administration Diversion Control Division issued solicitation 15DDHQ19Q00000009 for a firm-fixed-price procurement to conduct in vivo pharmacological studies. The primary objective of this contract is to evaluate the abuse potential of synthetic cathinones and other stimulant substances through drug discrimination and locomotor activity assays. The scope of work requires the contractor to maintain a Schedule I researcher registration and adhere to strict drug sourcing and recordkeeping requirements. The contract structure includes a base year and four option years, with detailed unit cost tables provided for the required assays. Throughout the solicitation process, several amendments were issued to update the Statement of Work, provide answers to vendor questions, and extend the proposal deadline, with the final extension moving the due date to February 28, 2019. Administrative oversight for this procurement is managed by the Office of Acquisition and Relocation Management in Springfield, Virginia, with specific requirements for vendors to submit a designated Past Performance Questionnaire.